98 related articles for article (PubMed ID: 9290954)
61. The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.
Geck P; Sonnenschein C; Soto AM
Am J Hum Genet; 2001 Aug; 69(2):461-3. PubMed ID: 11452363
[No Abstract] [Full Text] [Related]
62. New molecular targets in meningiomas: the present and the future.
Venur VA; Santagata S; Galanis E; Brastianos PK
Curr Opin Neurol; 2018 Dec; 31(6):740-746. PubMed ID: 30379704
[TBL] [Abstract][Full Text] [Related]
63. Identification and characterization of a microsatellite marker within murine Brca2 gene.
Sharan SK; Bradley A
Mamm Genome; 1997 Jan; 8(1):79. PubMed ID: 9021166
[No Abstract] [Full Text] [Related]
64. Letter: Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease.
Lu JQ; Reddy K
Neurosurgery; 2019 Aug; 85(2):E396. PubMed ID: 31058976
[No Abstract] [Full Text] [Related]
65. Regression of Multiple Meningiomas after Discontinuation of Chronic Hormone Therapy: A Case Report.
Shahin MN; Bowden SG; Yaghi NK; Bagley JH; Han SJ; Varlamov EV; Grafe MR; Cetas JS
J Neurol Surg Rep; 2021 Oct; 82(4):e38-e42. PubMed ID: 34877245
[No Abstract] [Full Text] [Related]
66. Correction to: The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.
Robert SM; Vetsa S; Nadar A; Vasandani S; Youngblood MW; Gorelick E; Jin L; Marianayagam N; Erson-Omay EZ; Günel M; Moliterno J
J Neurooncol; 2022 Jan; 156(2):215. PubMed ID: 34967924
[No Abstract] [Full Text] [Related]
67. Correction: Genomic profiling of sporadic multiple meningiomas.
Erson-Omay EZ; Vetsa S; Vasandani S; Barak T; Nadar A; Marianayagam NJ; Yalcin K; Miyagishima D; Aguilera SM; Robert S; Mishra-Gorur K; Fulbright RK; McGuone D; Günel M; Moliterno J
BMC Med Genomics; 2022 Jun; 15(1):131. PubMed ID: 35698142
[No Abstract] [Full Text] [Related]
68. TERT Alterations in Progressive Treatment-Resistant Meningiomas.
Juratli TA; Brastianos PK; Cahill DP
Neurosurgery; 2018 Sep; 65(CN_suppl_1):66-68. PubMed ID: 31076787
[No Abstract] [Full Text] [Related]
69. Robotic Stereotactic Radiotherapy for Intracranial Meningiomas-An Opportunity for Radiation Dose De-Escalation.
Grzbiela H; Nowicka E; Gawkowska M; Tarnawska D; Tarnawski R
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001695
[TBL] [Abstract][Full Text] [Related]
70. Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas.
Hemmer S; Urbschat S; Oertel J; Ketter R
Mol Cytogenet; 2019; 12():22. PubMed ID: 31139260
[TBL] [Abstract][Full Text] [Related]
71. Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer.
Lavrador JP; Pinto MV; Lemos LM; Ribeiro C; Santos AP
J Neurooncol; 2018 Jan; 136(1):163-171. PubMed ID: 29119423
[TBL] [Abstract][Full Text] [Related]
72. Zinc and zinc-containing biomolecules in childhood brain tumors.
Hrabeta J; Eckschlager T; Stiborova M; Heger Z; Krizkova S; Adam V
J Mol Med (Berl); 2016 Nov; 94(11):1199-1215. PubMed ID: 27638340
[TBL] [Abstract][Full Text] [Related]
73. Association of tamoxifen with meningioma: a population-based study in Sweden.
Ji J; Sundquist J; Sundquist K
Eur J Cancer Prev; 2016 Jan; 25(1):29-33. PubMed ID: 25642792
[TBL] [Abstract][Full Text] [Related]
74. Meningioma and schwannoma risk in adults in relation to family history of cancer.
Hill DA; Linet MS; Black PM; Fine HA; Selker RG; Shapiro WR; Inskip PD
Neuro Oncol; 2004 Oct; 6(4):274-80. PubMed ID: 15494094
[TBL] [Abstract][Full Text] [Related]
75. Low frequency of replication errors in primary nervous system tumours.
Sobrido MJ; Pereira CR; Barros F; Forteza J; Carracedo A; Lema M
J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):369-75. PubMed ID: 10945812
[TBL] [Abstract][Full Text] [Related]
76. Analysis of the BRCA1 and BRCA2 genes in sporadic meningiomas.
Kirsch M; Zhu JJ; Black PM
Genes Chromosomes Cancer; 1997 Sep; 20(1):53-9. PubMed ID: 9290954
[TBL] [Abstract][Full Text] [Related]
77. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
78. Lack of genetic and epigenetic changes in meningiomas without NF2 loss.
van Tilborg AA; Morolli B; Giphart-Gassler M; de Vries A; van Geenen DA; Lurkin I; Kros JM; Zwarthoff EC
J Pathol; 2006 Mar; 208(4):564-73. PubMed ID: 16353169
[TBL] [Abstract][Full Text] [Related]
79. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
Rajan JV; Marquis ST; Gardner HP; Chodosh LA
Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
[TBL] [Abstract][Full Text] [Related]
80. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
